Gilles Divita
Chief Executive Officer Divincell
Seminars
Thursday 30th April 2026
Unlocking a Peptide-Based Platform for Targeted Delivery of Therapeutic Agents
11:00 am
- Rationally designing and optimizing AI-driven peptide-vectors for targeted delivery of different payloads including peptide, protein and RNA
- Demonstrating safety and characterization of peptide-based nanoparticles for extrahepatic delivery of RNA
- Leveraging a peptide-based nanoparticle platform for systemic targeted delivery of therapeutic mRNA: T cell engineering and tumor selectivity
NEW COMPANY
